ArticleEye (London, England)2016

Reply to 'Comment on: Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab'.

L C Olmos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.